BioNeutra Global logo

BGA - BioNeutra Global Share Price

C$0.3 0.0  0.0%

Last Trade - 03/03/21

Sector
Consumer Defensives
Size
Micro Cap
Market Cap £7.63m
Enterprise Value £10.3m
Revenue £16.4m
Position in Universe 1825th / 2678
Bullish
Bearish
Unlock BGA Revenue
Momentum
Relative Strength (%)
1m +35.4%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -19.4%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
13.1 16.0 26.0 32.1 37.7 37.7 +23.6%
-98.6 +760.4
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2020,BioNeutra Global Corp revenues decreased 31% to C$19.3M.Net loss applicable to common stockholders decreased 85% toC$1M. Revenues reflect a decrease in demand for theCompany's products and services due to unfavorable marketconditions. Lower net loss reflects Contingent lossdecrease from C$959K (expense) to C$0K, Bad Debt Expensedecrease from C$830K (expense) to C$0K.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BGA Revenue Unlock BGA Revenue

Net Income

BGA Net Income Unlock BGA Revenue

Normalised EPS

BGA Normalised EPS Unlock BGA Revenue

PE Ratio Range

BGA PE Ratio Range Unlock BGA Revenue

Dividend Yield Range

BGA Dividend Yield Range Unlock BGA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BGA EPS Forecasts Unlock BGA Revenue
Profile Summary

BioNeutra Global Corporation is engaged in the research and development, production and commercialization of food ingredients for neutraceutical, functional and mainstream foods. The Company focuses on oligosaccharides. The Company's product, VitaFiber, which is a functional and health food ingredient made from agricultural products. The Company produces VitaFiber using its processes that transforms starch molecules from agriculture cereal crops, including corn, wheat, barley, potato, or tapioca into the functional health molecules of isomalto-oligosaccharide (IMO). The Company's VitaFiber is a sweet fiber, providing low calorie and soluble prebiotic fiber for human digestive health and it is also non-genetically modified organisms (GMO), sugar-free and gluten-free. The Company's VitaFiber-IMO products include a dietary fiber, a prebiotic, manages gastrointestinal health and a low calorie health sweetener.

Directors
Last Annual December 31st, 2019
Last Interim September 30th, 2020
Incorporated March 8, 1996
Public Since November 5, 2014
No. of Shareholders: n/a
No. of Employees: n/a
Sector Consumer Defensives
Industry Food & Tobacco
Index
Exchange TSX Venture Exchange
Shares in Issue 46,448,787
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BGA Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BGA
Upcoming Events for BGA
Frequently Asked Questions for BioNeutra Global
What is the BioNeutra Global share price?

As of 03/03/21, shares in BioNeutra Global are trading at C$0.3, giving the company a market capitalisation of £7.63m. This share price information is delayed by 15 minutes.

How has the BioNeutra Global share price performed this year?

Shares in BioNeutra Global are currently trading at C$0.3 and the price has moved by 42.86% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the BioNeutra Global price has moved by 30.12% over the past year.

What are the analyst and broker recommendations for BioNeutra Global?

There are no analysts currently covering BioNeutra Global.

When will BioNeutra Global next release its financial results?

BioNeutra Global is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the BioNeutra Global dividend yield?

BioNeutra Global does not currently pay a dividend.

Does BioNeutra Global pay a dividend?

BioNeutra Global does not currently pay a dividend.

When does BioNeutra Global next pay dividends?

BioNeutra Global does not currently pay a dividend.

How do I buy BioNeutra Global shares?

To buy shares in BioNeutra Global you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of BioNeutra Global?

Shares in BioNeutra Global are currently trading at C$0.3, giving the company a market capitalisation of £7.63m.

Where are BioNeutra Global shares listed? Where are BioNeutra Global shares listed?

Here are the trading details for BioNeutra Global:

Country of listing: Canada
Exchange: CVE
Ticker Symbol: BGA
What kind of share is BioNeutra Global?

Based on an overall assessment of its quality, value and momentum, BioNeutra Global is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a BioNeutra Global share price forecast 2021?

We were not able to load any forecast data for BioNeutra Global.

How can I tell whether the BioNeutra Global share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like BioNeutra Global. Over the past six months, the relative strength of its shares against the market has been 45.66%. At the current price of C$0.3, shares in BioNeutra Global are trading at -24.89% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the BioNeutra Global PE Ratio?

We were not able to find PE ratio data for BioNeutra Global.

Who are the key directors of BioNeutra Global?

BioNeutra Global's management team is headed by:

Jianhua Zhu - PRE
C. H. William Cheung - IND
Branko Jankovic - CFO
Jason Theiss - IND
William Wei - IND
Curtis Sparrow - IND
Gonglai Yang - VPR
Who are the major shareholders of BioNeutra Global?

Here are the top five shareholders of BioNeutra Global based on the size of their shareholding:

Zhu (Jianhua) Individual Investor
Percentage owned: 22.33% (10.4m shares)
Lee (Frederick) Individual Investor
Percentage owned: 13.4% (6.22m shares)
Cheung (C H William) Individual Investor
Percentage owned: 0.79% (369k shares)
Barclay (Monica) Individual Investor
Percentage owned: 0.07% (31.0k shares)
Horner (Douglas Alan) Individual Investor
Percentage owned: 0.03% (16.0k shares)
Similar to BGA
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.